<p>Nutex Health Inc.（纳斯达克代码：NUTX - 获取免费报告）在周二的交易中股价创下 52 周新高。该公司股价最高达到 187.20 美元，最后交易价格为 181.06 美元，交易量为 283744 股。该股票此前收盘价为 160.95 美元。</p>
<h2>分析师设定新目标价</h2>
<p>几家研究公司最近对 NUTX 进行了评估。Maxim Group 在 8 月 26 日的研究报告中将 Nutex Health 的目标价设定为 205.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在 12 月 1 日的研究报告中重新发布了对 Nutex Health 股票的 “持有（c）” 评级。最后，Wall Street Zen 在 11 月 28 日的报告中将 Nutex Health 的评级从 “买入” 上调至 “强力买入”。两位研究分析师对该股票给予了买入评级，一位则给予了持有评级。根据 MarketBeat.com 的数据，Nutex Health 目前的平均评级为 “适度买入”，平均目标价为 252.50 美元。</p>
<p><strong>阅读我们关于 Nutex Health 的最新股票报告</strong></p>
<h2>Nutex Health 股价上涨 12.5%</h2>
<p>该公司的市值为 12.8 亿美元，市盈率为 9.79，贝塔值为-0.03。该公司的 50 日简单移动平均线为 118.38 美元，200 日简单移动平均线为 111.96 美元。公司的流动比率为 3.20，速动比率为 3.18，债务与股本比率为 0.67。</p>
<p>Nutex Health（纳斯达克代码：NUTX - 获取免费报告）最近于 11 月 18 日发布了季度财报。该公司报告每股收益为 7.76 美元，超出市场共识预期的（5.43 美元）13.19 美元。Nutex Health 的股本回报率为 37.44%，净利润率为 11.62%。该公司在本季度的收入为 2.4399 亿美元，而分析师的预期为 2.2193 亿美元。</p>
<h2>内部人士活动</h2>
<p>在相关消息中，首席财务官 Jon Christian Bates 于 11 月 25 日购买了 750 股 Nutex Health 股票。该股票的平均购买成本为每股 136.71 美元，总交易额为 102,532.50 美元。购买完成后，首席财务官直接持有该公司 5,638 股股票，价值 770,770.98 美元。此次交易使其持股增加了 15.34%。该购买在向 SEC 的法律文件中披露，相关信息可通过 SEC 网站获取。目前，36.92% 的股票由内部人士持有。</p>
<h2>机构投资者对 Nutex Health 的看法</h2>
<p>机构投资者和对冲基金最近增加或减少了对该股票的持股。美国银行（Bank of America Corp DE）在第四季度将其在 Nutex Health 的持股增加了 6590.3%。美国银行（Bank of America Corp DE）目前持有该公司 2,074 股股票，价值 66,000 美元，此前在上个季度又购买了 2,043 股。Informed Momentum Co LLC 在第一季度购买了 Nutex Health 的新股份，价值为 868,000 美元。American Century Companies Inc.在第一季度将其在 Nutex Health 的持股增加了 73.0%。American Century Companies Inc.目前持有 74,359 股该公司股票，价值为 3,497,000 美元，此前在该期间又收购了 31,366 股。OMERS ADMINISTRATION Corp 在第一季度将其在 Nutex Health 的持股增加了 28.8%。OMERS ADMINISTRATION Corp 目前持有 9,400 股该公司股票，价值为 442,000 美元，此前在上个季度又购买了 2,100 股。最后，高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Nutex Health 的持股增加了 17.9%。高盛集团（Goldman Sachs Group Inc.）目前持有 18,119 股该公司股票，价值为 852,000 美元，此前在上个季度又购买了 2,748 股。对冲基金和其他机构投资者持有该公司 5.32% 的股票。</p>
<h2>Nutex Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Nutex Health Inc.是一家由医生主导的医疗服务和运营公司。它通过三个部门运营：医院、人口健康管理（PHM）和房地产。PHM 部门建立并运营独立的医生协会；并为医疗组织提供基于云的平台，以提供基于价值的护理和人口健康管理。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 Nutex Health</li>
<li>股票平均计算器</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>万亿美元市值的意义超越数字</li>
<li>2026 年最有可能拆分的三只股票</li>
<li>外汇是什么，它是如何运作的？</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次上涨</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Nutex Health 吗？</h2>
<p>在考虑 Nutex Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Nutex Health 并不在名单上。</p>
<p>虽然 Nutex Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

NUTX

<p>Nutex Health（纳斯达克代码：NUTX）股票达到新的 52 周高点，交易价格高达 187.20 美元。分析师们设定了新的价格目标，Maxim Group 将其评级为 “买入”，目标价为 205.00 美元。机构投资者调整了他们的持股，美国银行大幅增加了其持股。该公司报告了强劲的季度收益，超出预期，每股收益为 7.76 美元，收入为 2.4399 亿美元。内部人士活动包括首席财务官 Jon Christian Bates 购买股票，增加了 15.34% 的持股比例。Nutex Health 专注于医疗服务，涵盖医院、PHM 和房地产领域</p>

<p>Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $187.20 and last traded at $181.06, with a volume of 283744 shares traded. The stock had previously closed at $160.95.</p>
<div class="lb-trans"><p>Nutex Health Inc.（纳斯达克代码：NUTX - 获取免费报告）在周二的交易中股价创下 52 周新高。该公司股价最高达到 187.20 美元，最后交易价格为 181.06 美元，交易量为 283744 股。该股票此前收盘价为 160.95 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several research firms recently weighed in on NUTX. Maxim Group set a $205.00 price target on Nutex Health and gave the stock a &#34;buy&#34; rating in a research note on Tuesday, August 26th. Weiss Ratings reissued a &#34;hold (c)&#34; rating on shares of Nutex Health in a research note on Monday, December 1st. Finally, Wall Street Zen upgraded Nutex Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Nutex Health currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $252.50.</p>
<div class="lb-trans"><p>几家研究公司最近对 NUTX 进行了评估。Maxim Group 在 8 月 26 日的研究报告中将 Nutex Health 的目标价设定为 205.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在 12 月 1 日的研究报告中重新发布了对 Nutex Health 股票的 “持有（c）” 评级。最后，Wall Street Zen 在 11 月 28 日的报告中将 Nutex Health 的评级从 “买入” 上调至 “强力买入”。两位研究分析师对该股票给予了买入评级，一位则给予了持有评级。根据 MarketBeat.com 的数据，Nutex Health 目前的平均评级为 “适度买入”，平均目标价为 252.50 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Nutex Health</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Nutex Health 的最新股票报告</strong></p>
</div><h2>Nutex Health Trading Up 12.5%</h2>
<div class="lb-trans"><h2>Nutex Health 股价上涨 12.5%</h2>
</div><p>The firm has a market capitalization of $1.28 billion, a PE ratio of 9.79 and a beta of -0.03. The firm has a 50 day simple moving average of $118.38 and a 200 day simple moving average of $111.96. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67.</p>
<div class="lb-trans"><p>该公司的市值为 12.8 亿美元，市盈率为 9.79，贝塔值为-0.03。该公司的 50 日简单移动平均线为 118.38 美元，200 日简单移动平均线为 111.96 美元。公司的流动比率为 3.20，速动比率为 3.18，债务与股本比率为 0.67。</p>
</div><p>Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The firm had revenue of $243.99 million during the quarter, compared to analysts' expectations of $221.93 million.</p>
<div class="lb-trans"><p>Nutex Health（纳斯达克代码：NUTX - 获取免费报告）最近于 11 月 18 日发布了季度财报。该公司报告每股收益为 7.76 美元，超出市场共识预期的（5.43 美元）13.19 美元。Nutex Health 的股本回报率为 37.44%，净利润率为 11.62%。该公司在本季度的收入为 2.4399 亿美元，而分析师的预期为 2.2193 亿美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部人士活动</h2>
</div><p>In related news, CFO Jon Christian Bates purchased 750 shares of Nutex Health stock in a transaction dated Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares of the company's stock, valued at $770,770.98. The trade was a 15.34% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 36.92% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席财务官 Jon Christian Bates 于 11 月 25 日购买了 750 股 Nutex Health 股票。该股票的平均购买成本为每股 136.71 美元，总交易额为 102,532.50 美元。购买完成后，首席财务官直接持有该公司 5,638 股股票，价值 770,770.98 美元。此次交易使其持股增加了 15.34%。该购买在向 SEC 的法律文件中披露，相关信息可通过 SEC 网站获取。目前，36.92% 的股票由内部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Nutex Health</h2>
<div class="lb-trans"><h2>机构投资者对 Nutex Health 的看法</h2>
</div><p>Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Informed Momentum Co LLC purchased a new stake in Nutex Health during the first quarter valued at $868,000. American Century Companies Inc. lifted its holdings in Nutex Health by 73.0% in the first quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock valued at $3,497,000 after acquiring an additional 31,366 shares during the period. OMERS ADMINISTRATION Corp boosted its position in Nutex Health by 28.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock worth $442,000 after purchasing an additional 2,100 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock worth $852,000 after purchasing an additional 2,748 shares during the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近增加或减少了对该股票的持股。美国银行（Bank of America Corp DE）在第四季度将其在 Nutex Health 的持股增加了 6590.3%。美国银行（Bank of America Corp DE）目前持有该公司 2,074 股股票，价值 66,000 美元，此前在上个季度又购买了 2,043 股。Informed Momentum Co LLC 在第一季度购买了 Nutex Health 的新股份，价值为 868,000 美元。American Century Companies Inc.在第一季度将其在 Nutex Health 的持股增加了 73.0%。American Century Companies Inc.目前持有 74,359 股该公司股票，价值为 3,497,000 美元，此前在该期间又收购了 31,366 股。OMERS ADMINISTRATION Corp 在第一季度将其在 Nutex Health 的持股增加了 28.8%。OMERS ADMINISTRATION Corp 目前持有 9,400 股该公司股票，价值为 442,000 美元，此前在上个季度又购买了 2,100 股。最后，高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Nutex Health 的持股增加了 17.9%。高盛集团（Goldman Sachs Group Inc.）目前持有 18,119 股该公司股票，价值为 852,000 美元，此前在上个季度又购买了 2,748 股。对冲基金和其他机构投资者持有该公司 5.32% 的股票。</p>
</div><h2>Nutex Health Company Profile</h2>
<div class="lb-trans"><h2>Nutex Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.</p>
<div class="lb-trans"><p>Nutex Health Inc.是一家由医生主导的医疗服务和运营公司。它通过三个部门运营：医院、人口健康管理（PHM）和房地产。PHM 部门建立并运营独立的医生协会；并为医疗组织提供基于云的平台，以提供基于价值的护理和人口健康管理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Nutex Health</li>
<li>Stock Average Calculator</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>3 Stocks Most Likely to Split in 2026</li>
<li>What is Forex and How Does it Work?</li>
<li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Nutex Health</li>
<li>股票平均计算器</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>万亿美元市值的意义超越数字</li>
<li>2026 年最有可能拆分的三只股票</li>
<li>外汇是什么，它是如何运作的？</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次上涨</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Nutex Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Nutex Health 吗？</h2>
</div><p>Before you consider Nutex Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Nutex Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Nutex Health 并不在名单上。</p>
</div><p>While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Nutex Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Nutex Health（NASDAQ:NUTX）创下新的 1 年高点 - 事情经过如下